430 related articles for article (PubMed ID: 17265441)
1. Chitosan-thioglycolic acid conjugate: an alternative carrier for oral nonviral gene delivery?
Martien R; Loretz B; Thaler M; Majzoob S; Bernkop-Schnürch A
J Biomed Mater Res A; 2007 Jul; 82(1):1-9. PubMed ID: 17265441
[TBL] [Abstract][Full Text] [Related]
2. Oral gene delivery: design of polymeric carrier systems shielding toward intestinal enzymatic attack.
Martien R; Loretz B; Schnürch AB
Biopolymers; 2006 Nov; 83(4):327-36. PubMed ID: 16609969
[TBL] [Abstract][Full Text] [Related]
3. Synergistic effects of conjugating cell penetrating peptides and thiomers on non-viral transfection efficiency.
Rahmat D; Khan MI; Shahnaz G; Sakloetsakun D; Perera G; Bernkop-Schnürch A
Biomaterials; 2012 Mar; 33(7):2321-6. PubMed ID: 22169137
[TBL] [Abstract][Full Text] [Related]
4. In situ gelling properties of chitosan-thioglycolic acid conjugate in the presence of oxidizing agents.
Sakloetsakun D; Hombach JM; Bernkop-Schnürch A
Biomaterials; 2009 Oct; 30(31):6151-7. PubMed ID: 19699516
[TBL] [Abstract][Full Text] [Related]
5. Role of sulfhydryl groups in transfection? A case study with chitosan-NAC nanoparticles.
Loretz B; Thaler M; Bernkop-Schnürch A
Bioconjug Chem; 2007; 18(4):1028-35. PubMed ID: 17552491
[TBL] [Abstract][Full Text] [Related]
6. The use of chitosan-6-mercaptonicotinic acid nanoparticles for oral peptide drug delivery.
Millotti G; Perera G; Vigl C; Pickl K; Sinner FM; Bernkop-Schnürch A
Drug Deliv; 2011 Apr; 18(3):190-7. PubMed ID: 21039318
[TBL] [Abstract][Full Text] [Related]
7. Development and in vitro evaluation of a thiomer-based nanoparticulate gene delivery system.
Schmitz T; Bravo-Osuna I; Vauthier C; Ponchel G; Loretz B; Bernkop-Schnürch A
Biomaterials; 2007 Jan; 28(3):524-31. PubMed ID: 16979757
[TBL] [Abstract][Full Text] [Related]
8. Drug permeability and mucoadhesion properties of thiolated trimethyl chitosan nanoparticles in oral insulin delivery.
Yin L; Ding J; He C; Cui L; Tang C; Yin C
Biomaterials; 2009 Oct; 30(29):5691-700. PubMed ID: 19615735
[TBL] [Abstract][Full Text] [Related]
9. Development and characterization of a new plasmid delivery system based on chitosan-sodium deoxycholate nanoparticles.
Cadete A; Figueiredo L; Lopes R; Calado CC; Almeida AJ; Gonçalves LM
Eur J Pharm Sci; 2012 Mar; 45(4):451-8. PubMed ID: 21986445
[TBL] [Abstract][Full Text] [Related]
10. Chitosan-modified poly(D,L-lactide-co-glycolide) nanospheres for plasmid DNA delivery and HBV gene-silencing.
Zeng P; Xu Y; Zeng C; Ren H; Peng M
Int J Pharm; 2011 Aug; 415(1-2):259-66. PubMed ID: 21645597
[TBL] [Abstract][Full Text] [Related]
11. Preparation and in vitro transfection efficiency of chitosan microspheres containing plasmid DNA:poly(L-lysine) complexes.
Aral C; Akbuga J
J Pharm Pharm Sci; 2003; 6(3):321-6. PubMed ID: 14738712
[TBL] [Abstract][Full Text] [Related]
12. Thiolated chitosan nanoparticles for the nasal administration of leuprolide: bioavailability and pharmacokinetic characterization.
Shahnaz G; Vetter A; Barthelmes J; Rahmat D; Laffleur F; Iqbal J; Perera G; Schlocker W; Dünnhaput S; Augustijns P; Bernkop-Schnürch A
Int J Pharm; 2012 May; 428(1-2):164-70. PubMed ID: 22421322
[TBL] [Abstract][Full Text] [Related]
13. Chitosan nanoparticle as gene therapy vector via gastrointestinal mucosa administration: results of an in vitro and in vivo study.
Zheng F; Shi XW; Yang GF; Gong LL; Yuan HY; Cui YJ; Wang Y; Du YM; Li Y
Life Sci; 2007 Jan; 80(4):388-96. PubMed ID: 17074366
[TBL] [Abstract][Full Text] [Related]
14. Thiolated chitosan nanoparticles: transfection study in the Caco-2 differentiated cell culture.
Martien R; Loretz B; Sandbichler AM; Schnürch AB
Nanotechnology; 2008 Jan; 19(4):045101. PubMed ID: 21817495
[TBL] [Abstract][Full Text] [Related]
15. Melatonin-loaded lecithin/chitosan nanoparticles: physicochemical characterisation and permeability through Caco-2 cell monolayers.
Hafner A; Lovrić J; Voinovich D; Filipović-Grcić J
Int J Pharm; 2009 Nov; 381(2):205-13. PubMed ID: 19596430
[TBL] [Abstract][Full Text] [Related]
16. A novel PEGylation of chitosan nanoparticles for gene delivery.
Zhang Y; Chen J; Zhang Y; Pan Y; Zhao J; Ren L; Liao M; Hu Z; Kong L; Wang J
Biotechnol Appl Biochem; 2007 Apr; 46(Pt 4):197-204. PubMed ID: 17147512
[TBL] [Abstract][Full Text] [Related]
17. [Chitosan nanoparticles as gene vector: effect of particle size on transfection efficiency].
Yang XR; Zong L; Yuan XY
Yao Xue Xue Bao; 2007 Jul; 42(7):774-9. PubMed ID: 17882964
[TBL] [Abstract][Full Text] [Related]
18. Receptor-mediated gene delivery by folate-poly(ethylene glycol)-grafted-trimethyl chitosan in vitro.
Zheng Y; Song X; He G; Cai Z; Zhou Y; Yu B; Xu J; Wei Y; Hou S
J Drug Target; 2011 Sep; 19(8):647-56. PubMed ID: 20964597
[TBL] [Abstract][Full Text] [Related]
19. Ultrapure chitosan oligomers as carriers for corneal gene transfer.
Klausner EA; Zhang Z; Chapman RL; Multack RF; Volin MV
Biomaterials; 2010 Mar; 31(7):1814-20. PubMed ID: 19879644
[TBL] [Abstract][Full Text] [Related]
20. Thiomer nanoparticles: stabilization via covalent cross-linking.
Barthelmes J; Dünnhaupt S; Hombach J; Bernkop-Schnürch A
Drug Deliv; 2011 Nov; 18(8):613-9. PubMed ID: 22111974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
